NeuroPhage adds $9M in venture money; EntreMed looks to China; AMAG touts Feraheme data;

@FierceBiotech: Navy maneuvers to bombard dengue fever in vaccine study. Story | Follow @FierceBiotech

@JohnCFierce: J&J wows analysts with early success of Zytiga Ph3 for prostate cancer. News | Follow @JohnCFierce

@RyanMFierce: Props to Bellicum Pharma, not only for the new $20M B round, but also for the transparent explanation of the deal. Release | Follow @RyanMFierce

> Cambridge, MA-based NeuroPhage Pharmaceuticals has added $9 million in venture cash from a Series B-1 round. Merieux Developpement and Shire contributed money to the round, which will fund its work on neurodegenerative diseases. Release

> Rockville, MD-based Entremed says that it is opening up a China office to help facilitate development efforts and improve the odds of an eventual approval of its lead therapy. Release

> AMAG Pharmaceuticals said its anemia drug Feraheme proved non-inferior to a standard therapy in a late-stage study. Report

> The U.K.'s Circassia says its ragweed allergy therapy reaped positive results in a Phase II clinical trial. Release

> The Mid-Atlantic Bio conference announced that the North Carolina Biotechnology Center has joined the Virginia Biotechnology Association, Tech Council of Maryland, and Mid-Atlantic Venture Association as a 2012 strategic partner. Release

Pharma News

@FiercePharma: More OTC drugs? FDA may allow more meds to go non-prescription. Consumer-use studies still required. Story | Follow @FiercePharma

> Health plans sue Big Pharma over co-pay coupons. Story

CRO News

> Biosimilars growth draws contract labs into the fray. More

> Survey: Look for strong growth in R&D outsourcing, shift to India and China. Report

> Frustrated Pfizer seeks Euro recruitment contractor for 'virtual' trial. Article

> Survey zeroes in on CRO frustrations. Item

Vaccines News

> Is Agenus on GSK's shopping list? More

> Inovio vaccine targets head and neck HPV subtypes. Report

> Gradalis' personalized cancer vaccine has FANGs. Story

> Microneedles trigger better responses to flu vaccine. Article

Manufacturing News

> AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others. Item

> Almac builds on U.S. expansion with $10M pharmaceutical packaging plant. Article

> FDA cites company making 'baby switching' protection kit. News

And Finally… Investigators at the University of Texas at Austin have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV for less than 10 cents a pop. Release